According to FutureWise analysis the market for peripheral intravenous catheters is expected to register a CAGR of 7.4% from 2023-2031.
Injection needles can cause needlestick injuries which is a serious concern for patients who need injections daily. Percutaneous wound injuries are generally caused due to the needle tips while disassembling, handling or during needle and syringe disposal. As per the Centers for Disease Control and Prevention, over 380,000 needlestick injuries have been reported in the United States every year. Such a high prevalence of needlestick injuries has made healthcare personnel in using drug delivery devices, thereby increasing the patient comfort and reducing the risk.
The peripheral intravenous catheter is a small tube that is placed in the peripheral vein for direct administering of medications into the circulation. Additionally, these catheters are also used for withdrawing blood for testing purposes. Advanced catheters are integrated with more safety features that prevent needlestick injuries. The peripheral IV catheters and the circulatory system are in direct contact which is why they are produced using silicone which is non-irritant in nature and it does not have any side effects even if the IV catheters are in a long-term contact with the circulatory system. The peripheral IV catheters have a major benefit of administering medicine directly into the flow of blood which is the reason it is commonly used for patients undergoing surgeries, emergency patients, paediatric patients, geriatric patients and patients who are unable to swallow food. Such factors shall boost the peripheral intravenous catheters market growth. However, the need for trained healthcare professionals and the pain associated with the insertion procedure along with the expense of closed catheters shall impede the market growth to a certain extent.